Home
About
Overview
Sharing Data
ORCID
Help
History (5)
A balloon-expandable sheath facilitates transfemoral TAVR in patients with peripheral vascular disease and tortuosity.
FMRP links optimal codons to mRNA stability in neurons.
Gout Suppressants
Psychiatric Presentations and Medication Use in Older Adults With Intellectual and Developmental Disabilities.
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.
Gulati S, Shaughnessy J, Ram S, Rice PA. Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine. Front Immunol. 2019; 10:321.
View in:
PubMed
subject areas
Animals
Bacterial Vaccines
Complement System Proteins
Epitopes
Gonorrhea
Humans
Lipopolysaccharides
Neisseria gonorrhoeae
Peptides
authors with profiles
Peter A Rice MD
Sanjay Ram MD
Jutamas Shaughnessy MD, PhD